期刊
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
卷 323, 期 19, 页码 1899-1900出版社
AMER MEDICAL ASSOC
DOI: 10.1001/jama.2020.6434
关键词
-
This Viewpoint discusses the risks to patients and public health posed by the FDA's politically pressured Emergency Use Authorization (EUA) of chloroquine and hydroxychloroquine for COVID-19 treatment, and proposes principles to follow to ensure new therapies are studied properly and quickly to maximize benefits and minimize risks to patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据